Therapeutic Potential of Natural Pharmacological Agents in the Treatment of Human DiseasesView this Special Issue
Essential Oils and Their Constituents as Anticancer Agents: A Mechanistic View
Exploring natural plant products as an option to find new chemical entities as anticancer agents is one of the fastest growing areas of research. Recently, in the last decade, essential oils (EOs) have been under study for their use in cancer therapy and the present review is an attempt to collect and document the available studies indicating EOs and their constituents as anticancer agents. This review enlists nearly 130 studies of EOs from various plant species and their constituents that have been studied so far for their anticancer potential and these studies have been classified as in vitro and in vivo studies for EOs and their constituents. This review also highlights in-depth various mechanisms of action of different EOs and their constituents reported in the treatment strategies for different types of cancer. The current review indicates that EOs and their constituents act by multiple pathways and mechanisms involving apoptosis, cell cycle arrest, antimetastatic and antiangiogenic, increased levels of reactive oxygen and nitrogen species (ROS/RNS), DNA repair modulation, and others to demonstrate their antiproliferative activity in the cancer cell. The effect of EOs and their constituents on tumour suppressor proteins (p53 and Akt), transcription factors (NF-κB and AP-1), MAPK-pathway, and detoxification enzymes like SOD, catalase, glutathione peroxidase, and glutathione reductase has also been discussed.
Cancer has emerged as one of the most alarming diseases in the last few decades throughout the world. It is a multifactorial disease contributing towards uncontrolled growth and invasion of the abnormal cells leading to the formation of tumour. The steep rise in the number of cancer cases may be attributed to the change in food habits, use of tobacco and alcohol, chronic infections, exposure to harmful radiations and chemicals, or more widely due to change in lifestyle and environmental pollution . International Agency for Research on Cancer (IARC) reported that there are approximately 12 million cancer cases and these have accounted for 7.6 million deaths (around 13% of all deaths) in the year 2008 . The recent estimates reveal that the number of new cancer cases and cancer-related deaths has increased by 11% and 7.9, respectively, in the year 2012 as compared to 2008 . Further, the developing countries have half the number of cancer incidence cases compared to the developed countries . In India, 0.979 million cancer cases were reported in the year 2010 which is expected to increase to 1.148 million by 2020 . The mortality rate among cancer patients is very high. The problem is more serious in economically less developed countries due to the lack of diagnostic techniques, standard methods of treatment, and higher cost of the treatment . People in scientific field are currently overcoming these problems with the use of synthetic drugs. These drugs are designed to specifically target rapidly growing and dividing cells of various tumours. But, these synthetic drugs also affect rapidly dividing normal cells in our body leading to certain other major irreversible side effects. Chemotherapy used in cancer treatment has been reported to induce multidrug resistance [6, 7]. The high cost, increasing drug resistance, and side effects of current therapeutic approaches are forcing the scientists to explore alternative medicines, the traditional medicine, as an option to find new chemical entities for treatment of cancer.
Among the alternative traditional approaches, various plant products classified as alkaloids, saponins, triterpenes, glycosides, and polyphenols among others have shown very promising anticancer properties in both in vitro and in vivo. There are more than one thousand plants which have been reported to possess significant anticancer properties . Vincristine, vinblastine, colchicine, ellipticine, lepachol, taxol, podophyllotoxin, camptothecin, irinotecan, etoposide, and paclitaxel are classical examples of plant-derived compounds which are found to have wide applications in cancer therapeutics . The plant-derived products are expected to induce lesser side effects compared to synthetic drugs. Among plant derived compounds, essential oils (EOs) from aromatic plants have been reported to possess anticancer properties [10, 11]. EOs have also been reported to improve the quality of life of the cancer patients by lowering the level of their agony . EOs-mediated therapy cannot be a substitute to the standard chemotherapy and radiotherapy but can be used in combination with cancer therapy to decrease the side effects of the drugs. Hence, EOs can be used for improving the health of the cancer patients and as a source of novel anticancer compounds. In the last two decades, a number of researches are exploring anticancer potential of EOs and their components in vitro and in vivo models. Recently, Bhalla et al. reviewed EOs as anticancer agents limiting to the recent literature and a short mechanism(s) of action . However, the current review is a comprehensive one, enlisting nearly 130 studies of EOs from various plant species and their constituents that have been studied so far for their anticancer potential. The studies have been classified as in vitro and in vivo for EOs and their constituents. The current review also highlights in-depth various mechanisms of action of different EOs reported in the treatment strategies for different cancers.
2. Chemical Classification, Uses, and Therapeutic Potential of EOs and Their Constituents
EOs are the concentrated hydrophobic liquids with specific aroma produced by aromatic plants . These are also called volatile oils or ethereal oils and are the secondary metabolites present in lower amounts in various plant parts. The composition and other biological properties of the EOs depend on their constituents. The constituents may be terpenes, aromatic compounds and some other compounds of various origins. The constituents of the EOs have been classified on the basis of their chemical structures. EOs are considered more potent than their constituents  due to their synergistic and more selective effect. In addition, EOs from plants growing in varied environments differ in their composition and hence have different uses. A general classification based on chemical structures along with examples is enlisted in Table 1.
EOs and their components are used for their specific aromas in perfumery and as flavouring agents in food products since ancient times. EOs have also been used in aromatherapy for improving the health due to sedative and stimulant properties. EOs are used for massage, bath, and inhalation as relaxants and treatment options as aromatherapies for various diseases with active ingredients that are being exploited in medicine . The lipophilic nature of these EOs enables them to easily cross the membranes of the cells and reach inside the cell. EOs are described as strong antioxidants [10, 17] and antimicrobial  and are in use for the management of severe diseases like cardiovascular , diabetes , Alzheimer’s , cancer , and others. However, the present review focuses only on the anticancer potential of EOs and their constituents.
3. EO and Constituents as Anticancer Agents
EO is one among the most valuable plant products used in the medicine and complementary treatment strategies. Exploration of EOs and their constituents toward their beneficial role in different cancers is currently under lens. A search of PubMed (http://www.pubmed.gov/), the National Institute of Health’s online research shows 543 results for the search “cancer-essential oils” as of February 2014. Further screening of these research papers, nearly 135 correspond to anticancer properties of EO. Out of these 135 research papers, 117 have been published after the year 2005 indicating the sharp increase in number of publications in this field. EOs from different plants have been reported to have anticancer potential against mouth, breast, lung, prostate, liver cancer, colon cancer, and brain cancer and even in leukemia [23–28]. Not only EOs but their constituents like Carvacrol , d-limonene , Geraniols [31–33], Myrcene [34, 35], perillyl alcohol (POH) , α-humulene , β-caryophyllene , Thymol [39, 40], Citral , and others have also been reported to possess cytotoxic effect on the cancer cell lines and in vivo studies. Some of these like POH have gone through phase I  and phase II  clinical trials in cancer patients. Terpene analogues like Terpinen-4-ol have also been reported to have anticancer properties and induce apoptosis .
The current review has extensively collected and documented the available studies indicating EOs from many plants and their constituents as anticancer agents. The overall literature has been divided into different tables. Tables 2 and 3 document the in vivo and in vitro studies of EOs extracted from different plants against different cell lines along with the mechanism reported. Similarly, Table 4 documents in vivo and in vitro studies of constituents of EOs.
4. Mechanism of Action of EOs
Drugs used in cancer treatment target the cancer cell by inducing apoptosis or cell cycle arrest. Hence, natural products causing apoptosis in the cancer cells are valuable resources in cancer suppression. EOs with therapeutic potential can act by two ways—chemoprevention and cancer suppression. Various mechanisms involved in cancer treatment are activation of detoxification enzymes, modulation of DNA repair signaling, antimetastasis, and antiangiogenesis. Multiple pathways are involved in the antiproliferative activity demonstrated by the EOs in the cancer cells and EOs are even effective in reduction of tumours in animal models. Various targets of EOs for cancer prevention are represented in Figure 1. This makes EOs suitable anticancer agents with no large apparent effects being displayed on the normal cells. Attempts have been made to study various modes of inhibition of cancer cell growth by the EOs in this section.
4.1. Induction of Apoptosis
Apoptosis can occur due to effect on various signaling pathways, genetic material, and other cellular events like changes in the proteins at the intracellular level. Yu et al., using Bel-7402 cell line, had reported that the glutathione level in the body regulates cell proliferation . A study on human melanoma cells reported that treatment of EOs induces DNA damage in cancer cells which is an indicator of apoptosis . Apart from DNA damage, modification of various genes by the action of EOs is also responsible for apoptosis. Frank et al. studied the action of Boswellia carteri EO (frankincense oil) in bladder cancer cells and observed modulation of CDKN1A, DEDD2, IER3, IL6, SGK, TNFAIP3 GAD45B, and NUDT2 genes involved in apoptosis .
EOs were also demonstrated to change expression levels of Bcl-2 and Bax genes leading to release of cytochrome C into cytosol in KB human oral epidermoid carcinoma cells . This happens via activation of caspase-9 leading to caspase-3 formation which in turn cleaves target that causes apoptosis and increased phosphorylation of extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase, and p38 MAPK . EO-induced apoptosis has been also suggested to be involving mitochondrial and MAPKs pathways . Antiapoptotic Bcl-2 protein is downregulated by the action of EOs on the cancer cells . In mouth cancer KB cells, Artemisia lavandulaefolia EO has been shown to decrease Bcl-2 protein level in dose dependent manner , which leads to apoptosis in cancer cells that is an important strategy to control cancer development and progression.
EO constituents lead to poly(ADP-ribose) polymerase-1 (PARP) cleavage  which is an indicator of apoptosis . Major compounds of Salvia libanotica EO like linalyl acetate, terpineol, and camphor have been reported to be very effective against cancer. Synergistic activity of these compounds resulted in the antiproliferative effect on the isogenic colon cancer cell lines HCT-116 (p53+/+ and p53−/−) while no such effect was observed on normal intestinal cell line under similar conditions . Further, Itani et al. also concluded that, in p53+/+ cells, cancer cell death occurs via mitochondrial-mediated caspase dependent pathway while in the other cells, it occurs via caspase-independent way . PARP-1 protein has been shown to be modulated by the EOs and their constituents . Inactivation of PARP results due to the activity of caspases leading to cancer cell death in response to treatment with EOs and their constituents. In a study, Artemisia lavandulaefolia EO and its major compound 1,8-cineole have been shown to adopt the above route for mitochondrial and MAPKs pathways resulting in apoptosis in the mouth cancer, KB cells . EO of Boswellia sacra has also been reported to induce PARP cleavage in MDA-MB-231 cells . Some of the mechanisms leading to apoptosis are summarised below.
4.1.1. Increase in the ROS Levels
ROS are generated inside the cells in response to external stimuli or stress under normal conditions. Enhanced ROS levels in the abnormal cells instigate the cells to undergo apoptosis. Such response in the cancer cell on treatment with EO has been observed as an effective treatment method. EOs from Aniba rosaeodora (rosewood) were reported to induce apoptosis by increasing ROS production . Similar effect has been observed by the EO of Zanthoxylum schinifolium in liver (HepG2) cancer cells which leads to apoptosis . Decreased levels of cellular antioxidants like glutathione  and increased ROS production are the most commonly encountered phenomenon in cancer cells in response to the treatment with EOs that lead to cell death.
4.1.2. Effect on Akt
Akt is an important protein which also regulates p53, a tumour suppressor protein. Boswellia sacra oil influences the Akt protein expression . Vapor of Litsea cubeba seed oil suppressed mTOR and pPDK1 leading to dephosphorylation of Akt protein at serine (Ser473) and threonine (Thr308), respectively, activating various caspases (caspase 3 and caspase 9) which caused programmed cell death in lung cancer cells . They also reported that the cell cycle gets arrested in the lung cancer cells due to overexpression of p21 resulting from the deactivation of mdm2 due to dephosphorylated Akt protein. Further increased binding of the p21 to cyclins inhibited G1-S phase transition .
4.1.3. Effect on NF-κB
Nuclear factor, NF-κB, is a transcription factor (TF) that gets activated in the tumour cells . Thus, it serves as a potential target for developing anticancer drugs and blocking of this TF advocates towards anticancer activity of the natural compounds. α-terpineol have been reported to target NF-κB and downregulates its related genes such as IL-1β, IL1R1, IFNG, ITK, and EGFR . Linalyl acetate and α-terpineol monoterpenes act synergistically and inhibit the expression of NF-κB leading to cell death of colon cancer cells . Human leukaemia cell line (HL-60) treated with EO of Cymbopogon flexuosus and its major constituent isointermedeol has been reported to lower NF-κB which is one of the contributing multiple pathways resulting in apoptosis . EO of Artemisia capillaries leads to NF-κB-DNA binding activation at the concentration above 0.5 μL/mL, leading to apoptosis in the mouth cancer KB cells .
4.1.4. Effect on AP-1
Activator protein-1 (AP-1) is another TF which plays vital role in different processes like differentiation, proliferation, transformation, and apoptosis of the cells. Its activity is regulated by MAPK proteins which are also affected by EO treatment in cancer cells . Dietary intake of POH results in decreasing the tumours induced by Azoxymethane- (AOM-) induced colon cancer . It prevents the skin cancer induced by UV-B radiations  by activation of AP-1. DNA binding activity of AP-1 increases up on effective treatment of Artemisia capillaries EO resulting in apoptosis in mouth cancer cells . AP-1 thus is affected by the EO treatment and its activation mediate apoptosis in the cancer cells.
MAP kinases get activated in response to oxidative stress in the cells [61, 62]. Various MAPKs like JNK, ERK, and p38 kinase are the signaling molecules of MAPK pathway involved in the apoptosis in cancer cell. EOs mediated apoptosis involves phosphorylated MAPK forms in the cells . These forms increase with time of exposure to the EO of Artemisia capillaris in mouth cancer cells .
4.2. Cell Cycle Arrest
Mammalian cells have different cell cycle phases (G1, S, G2, and metaphase) to complete their life cycle. Fidelity of the cell cycle is lost due to the lack of response to the negative regulators of cell cycle progression in the cancer cells leading to uncontrolled cell division . Regulation of the genes involved in this process is also hampered. Thus, halting any cell cycle event in the cancer cell leads to prevention of their growth and division, a widely employed therapeutic strategy . Various cell cycle checkpoints act as potential targets for cancer treatment . Patchouli alcohol which is an important component of Pogostemon cablin EO has been reported to upregulate p21 expression and suppress cyclin D1 and cyclin-dependent kinase 4 (CDK4) expression in colorectal cancer cells with increase in dose . As p21 is negative regulator of G1 phase transition, increased expression of this protein by the action of patchouli alcohol is indicative of cell cycle inhibition . Similar arresting of the G1 transition has also been reported in different types of cancer in response to various other EOs [66, 67]. EOs of Curcuma wenyujin inhibit S/G2 phase transition leading to cancer cell death . G2/M phase transition has been reported on the treatment of liver tumour (J-5) cells with diallyl trisulfide, garlic EO constituents . Various constituents like geraniol, thymol, and carvacrol of EOs inhibit different phases of cell cycle [39, 70–72]. Monoterpenes act by altering the expression of cell cycle. Genes like DDIT3, IL8, and CDKNIA causing cell cycle arrest have been reported to be upregulated by frankincense oil . Therefore, EOs and their constituents serve as effective anticancer substances by targeting cell cycle progression in cancer cells.
4.3. Antimetastatic and Antiangiogenic
Angiogenesis is a process that occurs in the tumours, which helps them to survive and proliferate. Inhibition of this process stops the supply of required nutrients to the cancer cell and is an efficient way to control cancer. Certain anticancer drugs target cancer cell by this way. EO of Curcuma zedoaria has been tested in vitro and in vivo for antiangiogenic effect and it was reported to exhibit antiproliferative activity against various cancer cell lines and also suppressed melanoma growth and lung metastasis in mice . This action was reported to be attributed towards downregulation of matrix metalloproteinases (MMP) . POH which is one of the components of many EOs has been reported as the angiogenesis inhibitor molecule . EO from Citrus sinensis has been reported to inhibit angiogenesis and metastasis in colon cancer cells . Inhibition of vascular endothelial growth factor (VEGF) which plays an important role in angiogenesis is the key indicator of antiangiogenic behaviour displayed by the EOs . In addition, downregulation of matrix metalloproteases (MMP-6) by the Citrus sinensis EO in a dose dependent manner and blockage of vascular endothelial growth factor receptor 1 (VEGFR1) also confirmed the role of EO in inhibition of metastasis in colon cancer . Limonene and perillic acid are the antimetastatic molecules which are well studied in mice . α-Pinene isolated from the EO of Schinus terebinthifolius also had antimetastatic activity in the C57Bl/6 mice with melanomas . As both these processes are the most harmful and unique properties of the cancer cells, targeting these can prevent spreading of cancer to the other parts and inhibit proliferation of the localised tumours. Efficacy of the EOs in inhibiting these processes will enable potential treatment strategies for cancer therapy.
4.4. Effect on Detoxification Enzymes
Genotoxins lead to alteration of the internal antioxidants and antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) along with alteration of various important body functions resulting in damage to tissues and membranes. Phase I and phase II detoxification enzymes are responsible for the degradation of the harmful compounds. Certain compounds of the EOs act as inducer of these detoxification enzymes and thus prevent the induced-toxicity and even cancer in the cell line models. Citral is the example of one such compound which increases the activity of a key phase II detoxification enzyme—glutathione-S-transferase . Dietary intake of (POH) also plays a role in the prevention of carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone .
EOs have been reported to have preventive effect on cancer treatment . Varying concentrations of Allium sativum (garlic) EO were administered to mouse having diethylnitrosamine induced gastric cancer with basic diet and this EO affected phase I enzymes, SOD, CAT, and GPx activities. EO of Allium sativum has also been reported to be efficient in gastric cancer in mouse model . EOs induce phase I and phase II enzymes which prevent the interaction of carcinogens with DNA. This results in chemopreventive effect of the EOs [15, 81].
EO of holy basil prevents fibrosarcoma tumours induced by 20-methylcholanthrene in Swiss albino mice thighs by increasing the level of endogenous antioxidants . Ocimum sanctum EO affects enzymes, namely SOD, CAT, and GST, and increases the levels of reduced glutathione, a nonenzymatic antioxidant which is responsible for decrease in the size of tumour and its incidence in the mice with the induced toxicity . Salvia libanotica EO has potential to prevent the proliferation of skin papillomas induced by 7,12 dimethylbenz[a]anthracene (DMBA)- and 12-0-tetradecanoylphorbol-13-acetate (TPA) in mice . Pomegranate seed oil has ability to inhibit TPA induced skin cancer in the mice .
Antioxidant activity of EOs has been reported to be helpful in the scavenging of free radicals generated in the diseased state, leading to the cancer prevention. Wedelia chinensis EO has high antioxidant potential which was evaluated in lung cancer cell line implanted in C57BL/6 mice . Increase in the activity of antioxidant enzymes like CAT, SOD, and GPx along with increased level of glutathione was observed in the mice model, showing the preventive effect of these EOs even in the in vivo models . A proposed overall mechanism by which EOs display anticancer activity is presented in Figure 2.
4.5. Modulation of DNA Damage and Repair Signaling by EOs
Increased ROS production (as discussed above) results in DNA damage and can lead to the cell death. EOs have potential to induce damages at the DNA level that drives the cancer cells towards cell death. This activity is especially harmful in cancer cells, while no such damage is encountered in the normal cells; this provides added advantage of using these EOs. Targeting DNA repair pathways is an effective treatment method currently in use in the cancer to encounter the high proliferation rate in the cancer cells [86, 87].
One of the peculiar properties of the EOs is that though being cytotoxic to cancer cells, these induce proliferation of the normal cells . DNA repair potential is present in various EOs and their constituents. Cells pretreated with the compounds like linalool, myrcene, and eucalyptol were studied for repair activity by their recovery on the normal media and it was found that these can reduce the damage caused by hydrogen peroxide (H2O2), a potential genotoxin, but their coadministration is not that beneficial . Effect of the monoterpenes was dependent on the concentrations used and these had themselves induced breaks in DNA at higher concentrations . Therefore, their dose response studies are important from therapeutic point of view. Camphor and thujone  are other monoterpenes reported to mediate via DNA repair process in the cells with induced toxicity and also known as antimutagenic in mammalian cells . Thymus species EO was comparatively nontoxic to the normal fibroblast cells than MCF-7 and LNCaP human cancer cell lines . IC50 values of Tetraclinis articulate EO on blood lymphocytes were reported almost double than for different cancer cells .
On the other hand, targeting the DNA repair pathways is helpful in cancer therapy as cells become reluctant to chemotherapy. Downregulation of the repair genes by the EOs can prove to be effective treatment strategy towards targeting DNA repair processes. Genes like H2AFX and HDAC4 are responsible for DNA repair and cell cycle progression and were found to be suppressed by frankincense oil in human bladder cancer (J82) cells using microarray analysis . Therefore, EOs inhibit the cancer cell progression and thereby showing anticancer properties.
More specifically, the DNA polymerases are the enzymes involved in DNA repair and replication (DNA polymerases α, δ, and ε). These have been reported to be very effective targets in the development of drugs for cancer treatment. EOs inhibit the activity of the DNA polymerases  and therefore can be used as chemotherapeutic agents in cancer treatment. Chamomile EO was found to be very strong mammalian polymerase (λ and α) inhibitor among many other EOs tested which account for their increased therapeutic potential against cancer . As polymerase α is a DNA replicative polymerase and polymerase λ is a DNA repair/recombination polymerase, hence inhibition of both these polymerases will be helpful in cancer therapeutics .
The important DNA damage signaling protein, namely, PARP-1, is most abundantly found nuclear protein almost in all eukaryotes other than yeast. It is the first protein to act on the damaged DNA (single strand DNA and double strand DNA breaks) and initiates the DNA repair by the process of PARsylation and recruiting other DNA repair proteins associated with Base Excision Repair (BER) [86, 92] and nonhomologous end joining (NHEJ) . Many EOs and their constituents lead to PARP cleavage . Proteolytic cleavage of PARP-1 by the action of EOs might be indicative of modification of the DNA repair process in the cancer cells. More elaborative studies are still required in the determination of the role of EOs in modulation of different repair pathways like BER and NHEJ in cancer prevention.
5. Multidrug Resistance (MDR) in Cancer: A Potential Set Back
Multidrug resistance (MDR) is the most frequently encountered problem in the cancer patients, which makes most of the routinely used anticancer drugs ineffective [7, 94]. Lots of research are oriented on circumventing this problem. This arises due to different mechanisms like induction of repair of the damaged DNA in response to drug, change in drug uptake capability, and change in the level and response of the targeted enzymes. Adenosine triphosphate cassette (ABC)-transporter family proteins confer MDR due to their increased activity . EOs can circumvent the reluctance of tumours to respond to the cytotoxic drugs . EOs of thyme are effective against widely used drugs like Adriamycin, Vincristine, and Cisplatin resistant ovarian cancer cell lines and, in addition, tumour size reduction was also observed in vivo which indicates the efficacy of the EO in mammalian system [96, 97]. Juniperus excels EO was effective against MDR P-glycoprotein-expressing CEM/ADR5000 leukemia cells and reversed their resistance indicating the use of EO in MDR treatment in cancer . Melaleuca alternifolia, tea tree oil, can ameliorate Adriamycin resistance in human melanoma cells and terpinen-1-ol is responsible for this activity . Various EO constituents are reported as the anti-MDR molecules and are summarized below.
Linalool, monoterpene alcohol, is a constituent of many EOs and is reported to increase the therapeutic potential of Doxorubicin in breast cancer cells MCF-7 (adriamycin resistant) by increasing its accumulation in these cells for effective response . It has also been reported to cause membrane damage in the Epirubicin-resistant lung cancer, H1299 cells . Emergence of Dox resistance is the other most widely encountered chemotherapeutic hurdle  in the treatment of cancer patients. Thymoquinone (TQ) is the constituent of Nigella sativa and various other EOs have been found to prevent Dox induced resistance in breast cancer (MCF-7/Dox) cells. It inhibits their growth, induces apoptosis by upregulation of phosphatase and tensin homolog (PTEN), leading to downregulation of Akt cell survival protein, and causes cell cycle arrest at G2/M phase . Use of the EOs as dietary supplements and coadministration with drugs can enhance the response to the treatment. However, limited studies are available in this aspect but EOs and their active constituents are the promising avenues for combating MDR in cancer patients. Hence, some EOs can be used as combinational therapy in cancer patients due to their beneficial effects after in-depth research on the capability to overcome MDR.
6. Prevention of Side Effects of Cancer Treatment
Cancer patients suffer from different side effects which can be preferentially reduced by alternative methods. EOs are used in the aromatherapy for reducing the agony of brain cancer patients . EO is efficient in depression and reduction of anxiety in cancer patients . Cancer patients undergoing chemotherapy, one of the most frequently used treatment method in cancer, are prone to various side effects . These are nausea and vomiting. Mentha spicata and M. piperita have been found to be effective in overcoming these emetic conditions (chemotherapy-induced nausea and vomiting, CINV) along with the reduction of expenditure on treatment in the cancer patients undergoing chemotherapy . EOs of Leptospermum scoparium and Kunzea ericoides were reported to prevent mucositis in the head and neck cancer patients undergoing radiotherapy when used in the preparation of mouthwash . Some cancer patients having metastatic tumorigenic ulcers of skin develop necrosis and malodour . Patients suffering from such malodour were reported to have improvement in their state on treatment of these ulcers with the mixture of EOs having eucalyptus, melaleuca, lemongrass, lemon, clove leaf, and thyme on a 40% ethanol base . Lavender EO is widely used in aromatherapy and is found to be beneficial in reducing the distress in cancer patients . Hence, EOs serve as the valuable preparations in amelioration of the side effects and sufferings of the cancer patients.
7. Conclusions and Future Perspectives
EOs have been used in medicine from the ancient times and the present review is an attempt to highlight their therapeutic and chemopreventive value with major emphasis on the mechanistic approaches. Main aim of summarizing the research in this area is to provide better understanding of various pathways and mode of action of different EOs. EO constituents are potent in cancer prevention and treatment. Novel potent anticancer molecules can be found in EOs which can further be exploited in therapeutics. EOs can efficiently be exploited in pharmaceutical preparations with more research and some of them are already in the different phases of clinical trials. EOs are more effective in the preliminary studies than the individual constituents. Further, EOs and their constituents can be evaluated as therapeutic agents and can be used in complementation to standard therapies. Research on EOs as anticancer therapeutic agents is still in growing stage and immense potential of the EOs needs to be explored due to the lack of target specific release. Further, studies including clinical trials are required along with the use of advanced techniques for the targeted organ-specific release of the EOs for making the treatment more effective.
|NCBI:||National Center for Biotechnology Information|
|IARC:||International Agency for Research on Cancer|
|WHO:||World Health Organisation|
|ERK:||Extracellular signal-regulated kinase|
|NF-κB:||Nuclear factor kappa-light-chain-enhancer of activated B cells|
|CDK4:||Cyclin-dependent kinase 4|
|VEGFR:||Vascular endothelial growth factor receptor|
|VEGF:||Vascular endothelial growth factor|
|MAPK:||Mitogen-activated protein kinases|
|ROS:||Reactive oxygen species|
|mTOR:||Mammalian target of rapamycin|
|Mdm:||Mouse double minute 2 homolog|
|p21:||CDK-interacting protein 1|
|BER:||Base excision repair|
|NHEJ:||Nonhomologous end joining|
|ABC-Transporter:||Adenosine Triphosphate Cassette (ABC)-Transporter|
|PTEN:||Phosphatase and tensin homolog|
Conflict of Interests
The authors have declared that no conflict of interests exists.
This research was supported by the Science and Engineering Research Board, New Delhi, India (SR/FT/LS-66/2011), Grant awarded to Sunil Mittal, and UGC-BSR start-up Grant no. 20-39(12)/2013(BSR) awarded to Anil K. Mantha In addition, Nandini Gautam acknowledges institutional financial support from CUPB. The authors thank Dr. Raj Kumar, Assistant Professor, Centre for Chemical and Pharmaceutical Sciences, for critical comments; J. Nagendra Babu, Assistant Professor, Centre for Environmental Science and Technology, for providing technical assistance; and Neetu Purohit, Centre for Comparative Literature, Central University of Punjab, Bathinda, Punjab (India), for proof reading the paper for typographic and linguistic errors. Because of the limited focus of the paper, many appropriate references could not be included, for which the authors apologize. The CUPB publication number provided for this review is P-010/14.
National Cancer Institute, “Cancer Topics : Environment,” 2013, http://www.cancer.gov/cancertopics/understandingcancer/environment/AllPages.View at: Google Scholar
J. Ferlay, I. Soerjomataram, M. Ervik et al., GLOBOCAN, 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase, no. 11 Lyon, France: International Agency for Research on Cancer, 2013http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf.
R. Takiar, D. Nadayil, and A. Nandakumar, “Projections of number of cancer cases in India (2010–2020) by cancer groups,” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 4, pp. 1045–1049, 2010.View at: Google Scholar
L. Naumovski, J. P. Quinn, D. Miyashiro et al., “Outbreak of ceftazidime resistance due to a novel extended-spectrum β- lactamase in isolates from cancer patients,” Antimicrobial Agents and Chemotherapy, vol. 36, no. 9, pp. 1991–1996, 1992.View at: Google Scholar
K. Nooter and H. Herweijer, “Multidrug resistance (mdr) genes in human cancer,” British Journal of Cancer, vol. 63, no. 5, pp. 663–669, 1991.View at: Google Scholar
M. Mitoshi, I. Kuriyama, H. Nakayama et al., “Effects of essential oils from herbal plants and citrus fruits on DNA polymerase inhibitory, cancer cell growth inhibitory, antiallergic, and antioxidant activities,” Journal of Agricultural and Food Chemistry, vol. 60, no. 45, pp. 11343–11350, 2012.View at: Publisher Site | Google Scholar
National Cancer Institute, “Aromatherapy and Essential Oils (PDQ),” http://www.cancer.gov/cancertopics/pdq/cam/aromatherapy/healthprofessional.View at: Google Scholar
O. Y. Celiktas, E. Kocabas, E. Bedir, F. V. Sukan, T. Ozek, and K. H. C. Baser, “Antimicrobial activities of methanol extracts and essential oils of Rosmarinus officinalis, depending on location and seasonal variations,” Food Chemistry, vol. 100, no. 2, pp. 553–559, 2007.View at: Publisher Site | Google Scholar
H. G. Lancelle, O. S. Giordano, M. E. Sosa, and C. E. Tonn, “Chemical composition of four essential oils from Eupatorium spp. biological activities toward Tribolium castaneum (Coleoptera: Tenebrionidae),” Revista de la Sociedad Entomológica Argentina, vol. 68, no. 3-4, pp. 329–338, 2009.View at: Google Scholar
M. R. F. Gomes, R. S. Schuh, A. L. B. Jacques et al., “Citotoxic activity evaluation of essential oils and nanoemulsions of Drimys angustifolia and D. brasiliensis on human glioblastoma (U-138 MG) and human bladder carcinoma (T24) cell lines in vitro,” Brazilian Journal of Pharmacognosy, vol. 23, no. 2, pp. 259–267, 2013.View at: Publisher Site | Google Scholar
S. K. Nanyonga, A. Opoku, F. B. Lewu, A. O. Oyedeji, and M. Singh, “Chemical composition, antioxidant activity and cytotoxicity of the essential oils of the leaves and stem of Tarchonanthus camphoratus,” African Journal of Pharmacy and Pharmacology, vol. 7, no. 7, pp. 360–367, 2013.View at: Google Scholar
J. A. Elegbede, C. E. Elson, A. Qureshi, M. A. Tanner, and M. N. Gould, “Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene,” Carcinogenesis, vol. 5, no. 5, pp. 661–664, 1984.View at: Google Scholar
S. Carnesecchi, Y. Schneider, J. Ceraline et al., “Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 298, no. 1, pp. 197–200, 2001.View at: Google Scholar
S. Carnesecchi, K. Langley, F. Exinger, F. Gosse, and F. Raul, “Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-fluorouracil treatment,” Journal of Pharmacology and Experimental Therapeutics, vol. 301, no. 2, pp. 625–630, 2002.View at: Publisher Site | Google Scholar
D. Mitić-Ćulafić, B. Žegura, B. Nikolić, B. Vuković-Gačić, J. Knežević-Vukčević, and M. Filipič, “Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells,” Food and Chemical Toxicology, vol. 47, no. 1, pp. 260–266, 2009.View at: Publisher Site | Google Scholar
G. H. Ripple, M. N. Gould, J. A. Stewart et al., “Phase I clinical trial of perillyl alcohol administered daily,” Clinical Cancer Research, vol. 4, no. 5, pp. 1159–1164, 1998.View at: Google Scholar
P. M. Döll-Boscardin, A. Sartoratto, B. H. L. de Noronha Sales Maia et al., “In vitro cytotoxic potential of essential oils of Eucalyptus benthamii and its related terpenes on tumor cell lines,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 342652, 8 pages, 2012.View at: Publisher Site | Google Scholar
V. Cardile, A. Russo, C. Formisano et al., “Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: chemical composition, antimicrobial activity and inhibitory effect on human melanoma cells,” Journal of Ethnopharmacology, vol. 126, no. 2, pp. 265–272, 2009.View at: Publisher Site | Google Scholar
J. D. Cha, S. E. Moon, H. Y. Kim, I. H. Cha, and K. Y. Lee, “Essential oil of artemisia capillaris induces apoptosis in KB cells via mitochondrial stress and caspase activation mediated by MAPK-stimulated signaling pathway,” Journal of Food Science, vol. 74, no. 9, pp. T75–T81, 2009.View at: Publisher Site | Google Scholar
W. S. Itani, S. H. El-Banna, S. B. Hassan, R. L. Larsson, A. Bazarbachi, and H. U. Gali-Muhtasib, “Anti colon cancer components from lebanese sage (Salvia libanotica) essential oil: mechanistic basis,” Cancer Biology and Therapy, vol. 7, no. 11, pp. 1765–1773, 2008.View at: Google Scholar
J. Sœur, L. Marrot, P. Perez et al., “Selective cytotoxicity of Aniba rosaeodora essential oil towards epidermoid cancer cells through induction of apoptosis,” Mutation Research-Genetic Toxicology and Environmental Mutagenesis, vol. 718, no. 1-2, pp. 24–32, 2011.View at: Publisher Site | Google Scholar
S. Y. Paik, K. H. Koh, S. M. Beak, S. H. Paek, and J. A. Kim, “The essential oils from Zanthoxylum schinifolium pericarp induce apoptosis of HepG2 human hepatoma cells through increased production of reactive oxygen species,” Biological and Pharmaceutical Bulletin, vol. 28, no. 5, pp. 802–807, 2005.View at: Publisher Site | Google Scholar
D. W. Kim, M. A. Sovak, G. Zanieski et al., “Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells,” Carcinogenesis, vol. 21, no. 5, pp. 871–879, 2000.View at: Google Scholar
S. B. Hassan, H. Gali-Muhtasib, H. Göransson, and R. Larsson, “Alpha terpineol: a potential anticancer agent which acts through suppressing NF-κB signalling,” Anticancer Research, vol. 30, no. 6, pp. 1911–1919, 2010.View at: Google Scholar
S. J. Deeb, Enhancement of Cell Death by Linalyl Acetate and α-terpineol through Targeting the Nuclear factor-κb Activation Pathway in Human Colon Cancer Cells, American University of Beirut, 2009.
A. Kumar, F. Malik, S. Bhushan et al., “An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells,” Chemico-Biological Interactions, vol. 171, no. 3, pp. 332–347, 2008.View at: Publisher Site | Google Scholar
B. S. Reddy, C. X. Wang, H. Samaha et al., “Chemoprevention of colon carcinogenesis by dietary perillyl alcohol,” Cancer Research, vol. 57, no. 3, pp. 420–425, 1997.View at: Google Scholar
M. Barthelman, W. Chen, H. L. Gensler, C. Huang, Z. Dong, and G. T. Bowden, “Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation,” Cancer Research, vol. 58, no. 4, pp. 711–716, 1998.View at: Google Scholar
X. Ni, M. M. Suhail, Q. Yang et al., “Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model,” BMC Complementary and Alternative Medicine, vol. 12, article 253, 2012.View at: Publisher Site | Google Scholar
H. Y. Wang, B. Cai, C. B. Cui, D. Y. Zhang, and B. F. Yang, “Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cells via mitochondria-controlled apoptotic pathway,” Yaoxue Xuebao, vol. 40, no. 1, pp. 27–31, 2005.View at: Google Scholar
T. J. Raphael and G. Kuttan, “Effect of naturally occurring monoterpenes carvone, limonene and perillic acid in the inhibition of experimental lung metastasis induced by B16F-10 melanoma cells,” Journal of Experimental and Clinical Cancer Research, vol. 22, no. 3, pp. 419–424, 2003.View at: Google Scholar
A. L. Matsuo, C. R. Figueiredo, D. C. Arruda et al., “α-Pinene isolated from Schinus terebinthifolius Raddi (Anacardiaceae) induces apoptosis and confers antimetastatic protection in a melanoma model,” Biochemical and Biophysical Research Communications, vol. 411, no. 2, pp. 449–454, 2011.View at: Publisher Site | Google Scholar
Y. Nakamura, M. Miyamoto, A. Murakami, H. Ohigashi, T. Osawa, and K. Uchida, “A phase II detoxification enzyme inducer from lemongrass: Identification of citral and involvement of electrophilic reaction in the enzyme induction,” Biochemical and Biophysical Research Communications, vol. 302, no. 3, pp. 593–600, 2003.View at: Publisher Site | Google Scholar
L. E. Lantry, Z. Zhang, F. Gao et al., “Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung,” Journal of Cellular Biochemistry, vol. 67, supplement 27, pp. 20–25, 1998.View at: Google Scholar
R. Li, W. C. Chen, W. P. Wang, W. Y. Tian, and X. G. Zhang, “Extraction of essential oils from garlic (Allium sativum) using ligarine as solvent and its immunity activity in gastric cancer rat,” Medicinal Chemistry Research, vol. 19, no. 9, pp. 1092–1105, 2010.View at: Publisher Site | Google Scholar
H. U. Gali-Muhtasib and N. I. Affara, “Chemopreventive effects of sage oil on skin papillomas in mice,” Phytomedicine, vol. 7, no. 2, pp. 129–136, 2000.View at: Google Scholar
J. J. Hora, E. R. Maydew, E. P. Lansky, and C. Dwivedi, “Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice,” Journal of Medicinal Food, vol. 6, no. 3, pp. 157–161, 2003.View at: Google Scholar
M. R. Kelley, L. Cheng, R. Foster et al., “Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer,” Clinical Cancer Research, vol. 7, no. 4, pp. 824–830, 2001.View at: Google Scholar
A. Jaafari, H. A. Mouse, E. M. Rakib et al., “Chemical composition and antitumor activity of different wild varieties of Moroccan thyme,” Brazilian Journal of Pharmacognosy, vol. 17, no. 4, pp. 477–491, 2007.View at: Google Scholar
B. Nikolić, D. Mitić-Ćulafić, B. Vuković-Gačić, and J. Knežević-Vukčević, “Modulation of genotoxicity and DNA repair by plant monoterpenes camphor, eucalyptol and thujone in Escherichia coli and mammalian cells,” Food and Chemical Toxicology, vol. 49, no. 9, pp. 2035–2045, 2011.View at: Publisher Site | Google Scholar
J. A. Buhagiar, M. T. C. Podesta, A. P. Wilson, M. J. Micallef, and S. Ali, “The induction of apoptosis in human melanoma, breast and ovarian cancer cell lines using an essential oil extract from the conifer Tetraclinis articulata,” Anticancer Research, vol. 19, no. 6 B, pp. 5435–5443, 1999.View at: Google Scholar
M. F. Ullah, “Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy,” Asian Pacific Journal of Cancer Prevention, vol. 9, no. 1, pp. 1–6, 2008.View at: Google Scholar
L. Ait M'Barek, H. Ait Mouse, A. Jaâfari et al., “Cytotoxic effect of essential oil of thyme (Thymus broussonettii) on the IGR-OV1 tumor cells resistant to chemotherapy,” Brazilian Journal of Medical and Biological Research, vol. 40, no. 11, pp. 1537–1544, 2007.View at: Google Scholar
M. Abdel-Aziz, Y. Badr, N. Kamal, and E. H. El-Khatib, “In-vivo combined effect of cypermethrin and diode laser irradiation: comet assay measurements of DNA damage in rat liver cells,” Arab Journal of Biotechnology, vol. 8, no. 2, pp. 293–306, 2005.View at: Google Scholar
A. Erdogan and A. Ozkan, “A comparative study of cytotoxic, membrane and DNA damaging effects of Origanum majorana's essential oil and its oxygenated monoterpene component linalool on parental and epirubicin-resistant H1299 cells,” Biologia, vol. 68, no. 4, pp. 754–761, 2013.View at: Publisher Site | Google Scholar
E.-S. A. Arafa, Q. Zhu, Z. I. Shah et al., “Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells,” Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 706, no. 1-2, pp. 28–35, 2011.View at: Publisher Site | Google Scholar
N. Hadfield, “The role of aromatherapy massage in reducing anxiety in patients with malignant brain tumours,” International journal of palliative nursing, vol. 7, no. 6, pp. 279–285, 2001.View at: Google Scholar
Z. Tayarani-Najaran, E. Talasaz-Firoozi, R. Nasiri, N. Jalali, and M. K. Hassanzadeh, “Antiemetic activity of volatile oil from Mentha spicata and Mentha piperita in chemotherapy-induced nausea and vomiting,” ecancermedicalscience, vol. 7, no. 1, article 290, 2013.View at: Publisher Site | Google Scholar
W. Maddocks-Jennings, J. M. Wilkinson, H. M. Cavanagh, and D. Shillington, “Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study,” European Journal of Oncology Nursing, vol. 13, no. 2, pp. 87–93, 2009.View at: Publisher Site | Google Scholar
M. E. Haisfield-Wolfe and C. Rund, “Malignant cutaneous wounds: a management protocol,” Ostomy/wound management, vol. 43, no. 1, pp. 56–66, 1997.View at: Google Scholar
G. A. Fawzy, H. Y. Al Ati, and A. A. El Gamal, “Chemical composition and biological evaluation of essential oils of Pulicaria jaubertii,” Pharmacognosy Magazine, vol. 9, no. 33, pp. 28–32, 2013.View at: Google Scholar
S. Stone, F. Vasconcellos, E. Lenardão, R. do Amaral, R. Jacob, and F. L. Leite, “Evaluation of potential use of Cymbopogon sp. essential oils, (R)-citronellal and N-citronellylamine in cancer chemotherapy,” International Journal of Applied Research in Natural Products, vol. 6, no. 4, pp. 11–15, 2013.View at: Google Scholar
E. B. P. da Silva, A. L. Matsuo, C. R. Figueiredo, M. H. Chaves, P. Sartorelli, and J. H. G. Lago, “Chemical constituents and cytotoxic evaluation of essential oils from leaves of Porcelia macrocarpa (Annonaceae),” Natural Product Communications, vol. 8, no. 2, pp. 277–279, 2013.View at: Google Scholar
E. Cetinus, T. Temiz, M. Ergül, A. Altun, Ş. Çetinus, and T. Kaya, “Thyme essential oil inhibits proliferation of DLD-1 colorectal cancer cells through antioxidant effect,” Cumhuriyet Medical Journal, vol. 35, no. 1, pp. 14–24, 2013.View at: Google Scholar
M. B. Majnooni, T. Ahmadi-Jouibari, M. R. Nikbakht, K. Mansouri, and G. Bahram, “Chemical composition and cytotoxic activity of the essential oil from Achillea wilhelmsii C. Koch,” Journal of Reports in Pharmaceutical Sciences, vol. 2, no. 2, pp. 9–13, 2013.View at: Google Scholar
R. P. C. Ferraz, G. M. B. Cardoso, T. B. da Silva et al., “Antitumour properties of the leaf essential oil of Xylopia frutescens Aubl (Annonaceae),” Food Chemistry, vol. 141, no. 1, pp. 196–200, 2013.View at: Google Scholar
M. S. Owolabi, A. L. Ogundajo, N. S. Dosoky, and W. N. Setzer, “The cytotoxic activity of Annona muricata leaf oil from Badagary, Nigeria,” The American Journal of Essential Oil and Natural Product, vol. 1, no. 1, pp. 1–3, 2013.View at: Google Scholar
S. Shahabipour, O. Firuzi, M. Asadollahi, M. Miri, and K. Javidnia, “Essential oil composition and cytotoxic activity of Libanotis transcaucasica schischk from Iran,” Natural Products Chemistry & Research, vol. 1, no. 108, pp. 1–2, 2013.View at: Google Scholar
F. S. Sharopov, M. Wink, D. R. Khalifaev, H. Zhang, N. S. Dosoky, and W. N. Setzer, “Composition and bioactivity of the essential oil of Melissa officinalis L. growing wild in Tajikistan,” International Journal of Traditional and Natural Medicines, vol. 2, no. 2, pp. 86–96, 2013.View at: Google Scholar
H. J. Harzallah, R. Grayaa, W. Kharoubi, A. Maaloul, M. Hammami, and T. Mahjoub, “Thymoquinone, the Nigella sativa bioactive compound, prevents circulatory oxidative stress caused by 1,2-dimethylhydrazine in erythrocyte during colon postinitiation carcinogenesis,” Oxidative medicine and cellular longevity, vol. 2012, Article ID 854065, 6 pages, 2012.View at: Publisher Site | Google Scholar
S. Sertel, T. Eichhorn, P. K. Plinkert, and T. Efferth, “Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma,” Anticancer Research, vol. 31, no. 1, pp. 81–87, 2011.View at: Google Scholar
V. Dwivedil, R. Shrivastaval, S. Hussain, C. Ganguly, and M. Bharadwaj, “Comparative anticancer potential of clove (Syzygium aromaticum)—an Indian spice—against cancer cell lines of various anatomical origin,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 8, pp. 1989–1993, 2011.View at: Google Scholar
T. Nagappan, P. Ramasamy, M. E. A. Wahid, T. C. Segaran, and C. S. Vairappan, “Biological activity of carbazole alkaloids and essential oil of Murraya koenigii against antibiotic resistant microbes and cancer cell lines,” Molecules, vol. 16, no. 11, pp. 9651–9664, 2011.View at: Publisher Site | Google Scholar
A. El Hadri, M. G. Del Río, J. Sanz et al., “Cytotoxic activity of α-humulene and transcaryophyllene from Salvia officinalis in animal and human tumor cells,” Anales de la Real Academia Nacional de Farmacia, vol. 76, no. 3, pp. 343–356, 2010.View at: Google Scholar
J. Z. Al-Kalaldeh, R. Abu-Dahab, and F. U. Afifi, “Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells,” Nutrition Research, vol. 30, no. 4, pp. 271–278, 2010.View at: Publisher Site | Google Scholar
H. Bendaoud, M. Romdhane, J. P. Souchard, S. Cazaux, and J. Bouajila, “Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus molle Raddi berries essential oils,” Journal of Food Science, vol. 75, no. 6, pp. C466–C472, 2010.View at: Publisher Site | Google Scholar
A. A. Mohamed, G. A. El-Emary, and H. F. Ali, “Influence of some Citrus essential oils on cell viability, glutathione-S-transferase and lipid peroxidation in Ehrlich ascites carcinoma cells,” Journal of American Science, vol. 6, no. 10, pp. 820–826, 2010.View at: Google Scholar
T. Patharakorn, T. Arpornsuwan, N. Wetprasit, A. Promboon, and S. Ratanapo, “Antibacterial activity and cytotoxicity of the leaf essential oil of Morus rotunbiloba Koidz,” Journal of Medicinal Plants Research, vol. 4, no. 9, pp. 837–843, 2010.View at: Google Scholar
H. C. Yan, P. Hong, Z. Z. Yu, and S. Jing, “Evaluation of antioxidant and antitumour activities of lemon essential oil,” Journal of Medicinal Plants Research, vol. 4, no. 18, pp. 1910–1915, 2010.View at: Google Scholar
A. I. Hussain, F. Anwar, S. A. S. Chatha, A. Jabbar, S. Mahboob, and P. S. Nigam, “Rosmarinus officinalis essential oil: antiproliferative, antioxidant and antibacterial activities,” Brazilian Journal of Microbiology, vol. 41, no. 4, pp. 1070–1078, 2010.View at: Google Scholar
J. R. Patil, G. K. Jayaprakasha, K. N. Chidambara Murthy, S. E. Tichy, M. B. Chetti, and B. S. Patil, “Apoptosis-mediated proliferation inhibition of human colon cancer cells by volatile principles of Citrus aurantifolia,” Food Chemistry, vol. 114, no. 4, pp. 1351–1358, 2009.View at: Publisher Site | Google Scholar
F. Conforti, F. Menichini, C. Formisano et al., “Comparative chemical composition, free radical-scavenging and cytotoxic properties of essential oils of six Stachys species from different regions of the Mediterranean Area,” Food Chemistry, vol. 116, no. 4, pp. 898–905, 2009.View at: Publisher Site | Google Scholar
A. C. Mesa-Arango, J. Montiel-Ramos, B. Zapata, C. Durán, L. Betancur-Galvis, and E. Stashenko, “Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (Mill.) N.E. Brown: composition, cytotoxicity and antifungal activity,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 6, pp. 878–884, 2009.View at: Google Scholar
S. A. Fayed, “Antioxidant and anticancer activities of Citrus reticulate (Petitgrain Mandarin) and Pelargonium graveolens (Geranium) essential oils,” Research Journal of Agriculture and Biological Sciences, vol. 5, no. 5, pp. 740–747, 2009.View at: Google Scholar
H. M. Ashour, “Antibacterial, antifungal, and anticancer activities of volatile oils and extracts from stems, leaves, and flowers of Eucalyptus sideroxylon and Eucalyptus torquata,” Cancer Biology and Therapy, vol. 7, no. 3, pp. 399–403, 2008.View at: Google Scholar
M. R. Loizzo, R. Tundis, F. Menichini, A. M. Saab, G. A. Statti, and F. Menichini, “Cytotoxic activity of essential oils from Labiatae and Lauraceae families against in vitro human tumor models,” Anticancer Research, vol. 27, no. 5, pp. 3293–3299, 2007.View at: Google Scholar
S. A. El-Sawi, H. M. Motawae, and A. M. Ali, “Chemical composition, cytotoxic activity and antimicrobial activity of essential oils of leaves and berries of Juniperus phoenicea L. grown in Egypt,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 4, no. 4, pp. 417–426, 2007.View at: Google Scholar
S. L. da Silva, P. M. Figueiredo, and T. Yano, “Cytotoxic evaluation of essential oil from Zanthoxylum rhoifolium Lam. leaves,” Acta Amazonica, vol. 37, no. 2, pp. 281–286, 2007.View at: Google Scholar
E. Bieberich, A. Sebastian, and N. H. Sarkar, “Neem-seed oil inhibits the growth of breast cancer cells,” Proceedings of the American Association for Cancer Research, vol. 2006, no. 1, article 456, 2006.View at: Google Scholar
M. A. Apel, M. E. L. Lima, A. Souza et al., “Screening of the biological activity from essential oils of native species from the Atlantic Rainforest (São Paulo-Brazil),” Pharmacologyonline (Salerno), vol. 3, pp. 376–383, 2006.View at: Google Scholar
R. Monajemi, S. Oryan, A. Haeri-Roohani, A. Ghannadi, and A. Jafarian, “Cytotoxic effects of essential oils of some Iranian Citrus peels,” Iranian Journal of Pharmaceutical Research, pp. 183–187, 2010.View at: Google Scholar
A. C. Gören, G. Topçu, G. Bilsel, M. Bilsel, Z. Aydoǧmuş, and J. M. Pezzuto, “The chemical constituents and biological activity of essential oil of Lavandula stoechas ssp. stoechas,” Zeitschrift für Naturforschung C: Journal of Biosciences, vol. 57, no. 9-10, pp. 797–800, 2002.View at: Google Scholar
L. T. Bidinotto, C. A. R. A. Costa, D. M. F. Salvadori, M. Costa, M. A. M. Rodrigues, and L. F. Barbisan, “Protective effects of lemongrass (Cymbopogon citratus STAPF) essential oil on DNA damage and carcinogenesis in female Balb/C mice,” Journal of Applied Toxicology, vol. 31, no. 6, pp. 536–544, 2011.View at: Publisher Site | Google Scholar
G. H. Kumar, R. Vidya Priyadarsini, G. Vinothini, P. Vidjaya Letchoumy, and S. Nagini, “The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis,” Investigational New Drugs, vol. 28, no. 4, pp. 392–401, 2010.View at: Publisher Site | Google Scholar
R. V. Priyadarsini, R. S. Murugan, P. Sripriya, D. Karunagaran, and S. Nagini, “The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells,” Free Radical Research, vol. 44, no. 6, pp. 624–634, 2010.View at: Publisher Site | Google Scholar
R. V. Priyadarsini, P. Manikandan, G. H. Kumar, and S. Nagini, “The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis,” Free Radical Research, vol. 43, no. 5, pp. 492–504, 2009.View at: Publisher Site | Google Scholar
S. J. Mehdi, A. Ahmad, M. Irshad, N. Manzoor, and M. M. A. Rizvi, “Cytotoxic effect of Carvacrol on human cervical cancer cells,” Biology and Medicine, vol. 3, no. 2, pp. 307–312, 2011.View at: Google Scholar
A. T. Koparal and M. Zeytinoglu, “Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549,” Cytotechnology, vol. 43, no. 1–3, pp. 149–154, 2003.View at: Google Scholar
J. E. Okokon, A. Dar, and M. I. Choudhary, “Immunomodulatory, cytotoxic and antileishmanial activity of phytoconstituents of Croton zambesicus,” Phytopharmacology Journal, vol. 4, no. 1, pp. 31–40, 2013.View at: Google Scholar
F. C. Huang, Y. Fan, and S. Zheng, “Effect of elemene on the telomerase activity, apoptosis and cell cycles of the colon cancer lovo cell line,” Herald of Medicine, vol. 10, pp. 713–715, 2004.View at: Google Scholar
A. Carrasco, C. Espinoza, V. Cardile et al., “Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (Part I),” Journal of the Brazilian Chemical Society, vol. 19, no. 3, pp. 543–548, 2008.View at: Google Scholar
B. B. R. Choi, S. H. Shin, U. K. Kim, J. W. Hong, and G. C. S. Kim, “Phase cell cycle arrest and apoptosis is induced by eugenol in G361 human melanoma cells,” International Journal of Oral Biology, vol. 36, no. 3, pp. 129–134, 2011.View at: Google Scholar
Y. Xiao, F. Q. Yang, S. P. Li et al., “Furanodiene induces G2/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells,” Cancer Biology and Therapy, vol. 6, no. 7, pp. 1044–1050, 2007.View at: Google Scholar
S. C. Gupta, S. Prasad, D. R. Sethumadhavan, M. S. Nair, Y. Y. Mo, and B. B. Aggarwal, “Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment,” Clinical Cancer Research, vol. 19, no. 16, pp. 4465–4476, 2013.View at: Publisher Site | Google Scholar
K. Kavitha, R. Vidya Priyadarsini, P. Anitha et al., “Nimbolide, a neem limonoid abrogates canonical NF-κB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells,” European Journal of Pharmacology, vol. 681, no. 1–3, pp. 6–14, 2012.View at: Publisher Site | Google Scholar
S. Babykutty, P. S. Priya, R. J. Nandini et al., “Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells,” Molecular Carcinogenesis, vol. 51, no. 6, pp. 475–490, 2012.View at: Publisher Site | Google Scholar
Q. H. Yin, Y. Z. Zhuang, and X. F. Yan, “Antitumor efficacy of thymol,” Progress in Modern Biomedicine, vol. 11, article 028, 2010.View at: Google Scholar
S. Santha, A. Bommareddy, B. Rule et al., “Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis,” PLoS ONE, vol. 8, no. 2, Article ID e56982, 2013.View at: Publisher Site | Google Scholar
J. Hu, W. Jin, and P. M. Yang, “Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by beta-elemene,” Zhonghua Zhong Liu Za Zhi, vol. 26, no. 5, pp. 268–270, 2004.View at: Google Scholar